Skip to content
‹ Back to IndustriesHealthcare

CDC Guidelines “Really Not Workable” According to Carnival CEO

U.S. cruises could resume by mid-summer with restrictions, the Centers for Disease Control and Prevention said. Carnival Chief Executive Officer Arnold Donald said the agency’s restrictions were “not workable,” and that the company considered setting its ships to sail from outside the U.S. Donald spoke with Bloomberg’s Carol Massar.   Donald: The CDC, I think,…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

U.S. cruises could resume by mid-summer with restrictions, the Centers for Disease Control and Prevention said. Carnival Chief Executive Officer Arnold Donald said the agency’s restrictions were “not workable,” and that the company considered setting its ships to sail from outside the U.S. Donald spoke with Bloomberg’s Carol Massar.

Donald: The CDC, I think, last October issued a conditional sail order and they came out in phases, the first phase was bringing ships back into us waters and it was primarily with minimal crew on board. We finished that phase of it in terms of having ourselves, 30 ships that are currently in green status. They issued on April 2nd, the next phase. And frankly, what has been issued doesn’t give us a specific time to be able to return and also is really not workable in the current form. But again, it just came out. And we have an opportunity to discuss with the CDC and the administration to make sure that we do have something that’s workable and hopefully that will allow us to be able to sail in July.

We’re hoping it will be something that’s more in line with the advancements of vaccines that’s occurred and the rapid advancement of the vaccines that the administration has been so successful with, as well as the advancement in treatments and the investments, the rapid testing, none of which existed when the original conditional sail order was written. So we’re hopeful that we’ll be able to meet with the administration and CDC and come up with something that’s practical and will allow people to return to their choice of vacation travel and get a whole lot of Americans back to work. As you know half million people were impacted in the US in terms of jobs associated with the cruise industry outside of the cruise companies themselves.

Host: It affects a lot of other jobs and other industries connected with the cruise industry. One thing I got to ask you, Arnold, is how much of Carnival threatening to relocate their ships to other markets outside the United states, do you think was the reason for the CDC change? Because it was just a few days ago that they came out, you know, and we’re still kind of holding firm what happened? What were the conversations that maybe you, you and other members of the cruise line industry had with the CDC?

Donald: There was no threat or anything, it’s just a practical reality that if we’re not able to sail from the US sometime soon, we would have to sail from elsewhere. And so some of the ships, what homeport in a number of companies have already announced home 40 ships that normally would have been selling out of the US home ported from different places in the Caribbean. But it’s not a threat or anything. It’s just a natural outcome of not being able to sail, you know, from the US. I’m not sure anything has changed. Perhaps it has. I haven’t heard directly from the CDC or the administration anything has changed. I think that they genuinely believe the information they put out might allow some limited sailing as early as July. And so we’ll have to discuss that with them. You know, our timelines don’t quite match up with that, but maybe we don’t understand everything.

The CDC has a job to do. They’re trying to do their job. I think as long as we work together with the CDC and the administration, we can all get crews, you know, back soon. And we can have all those half a million workers no longer suffer from not being able to earn a wage.

—

*Bloomberg contributed to this content

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Video TranscriptExpand ↓

The CDC, I think, last October issued a conditional sale order and they came out in phases, the first phase was bringing ships back into us waters and it was primarily with minimal crew on board. We finished that phase of it in terms of having it ourselves, 30 ships that are currently in green status. They issued on April 2nd, the next phase. And frankly, what has been issued doesn't give us a specific time to be able to return and also is really not workable in the current form. But again, it just came out. And we have an opportunity to discuss with the CDC and the administration to make sure that we do have something that's workable and hopefully that will allow us to be able to sail in July. And we're hoping it will be something that's more in line with the advancements of vaccines that's occurred and the rapid advancement of the vaccines that the administration has been so successful with, as well as the advancement and treatments and the investments, the rapid testing, none of which existed when the original conditional sale order was written. So we're hopeful that we'll be able to meet with the administration and CDC and come up with something that's practical and will allow people to return to their choice of vacation travel and get a whole lot of Americans back to work. As you know, Carol, of a half million people impacted in the US in terms of jobs associated with the cruise industry outside of the cruise companies themselves. Now, it affects a lot of other jobs. And other industries connected with the cruise industry. One thing I got to ask you, Arnold, is how much of carnival threatening to relocate their ships to other markets outside the United states, do you think was the reason for the CDC change? Because it was just a few days ago that they came out, you know, and we're still kind of holding firm what happened? What were the conversations that maybe you, you and other members of the cruise line industry had with the cdc? There was no threat or anything, it's just a practical reality that if we're not able to seal from the US and some monsoon, we would have to steal from elsewhere. And so some of the ships, what homeport in a number of companies have already announced home 40 ships that normally would have been selling out of the US home ported from different places in the Caribbean. But it's not a threat or anything. It's just a natural outcome of not being able to sail, you know, from the u.s., I'm not sure anything has changed. Perhaps it has. I haven't heard directly from the CDC or the administration anything has changed. I think that they genuinely believe the information they put out might allow some limited sailing as early as July. And so we'll have to discuss that with them. You know, our timelines don't quite match up with that, but maybe we don't understand everything. So the CDC has a job to do. They're trying to do their job. I think as long as we work together with the CDC and the administration, we can all get cruise, you know, back soon. And we can get it back. And safe was in the interest of public health. And we can have all those half a million workers no longer suffer from not being able to earn a wage.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Moderna swings to a profit and raises its 2026 revenue outlook as newer vaccines gain traction

Moderna swings to a profit and raises its 2026 revenue outlook as newer vaccines gain traction

Moderna reported third-quarter revenue of $1.31 billion, up 29%, and net income of $162 million, compared with a $200 million loss a year earlier. International COVID vaccine sales under long-term government partnerships and the full-year impact of its next-generation COVID vaccine drove growth, while lower costs helped the profit. The company raised its 2026 revenue growth outlook to 15% to 25% from up to 10%. Its flu shot, mFLUSIVA, was approved in the U.S. and will have a limited U.S. launch in 2026.

  • 01Third-quarter revenue rose 29% to $1.31 billion, with $780 million in the U.S. and $533 million internationally.
  • 02Net income was $162 million, or 38 cents per share, versus a $200 million loss a year earlier.
  • 03Moderna now expects 2026 revenue growth of 15% to 25%, up from up to 10%.

Nov 6, 2026

Why legacy EHR data decides whether healthcare AI pays off

Why legacy EHR data decides whether healthcare AI pays off

MediQuaid director of client services Jason Tennison, a former bedside nurse, discussed EHR replacement data challenges on the Scopewell podcast, where host James Leuthe credited him with an analogy that clean, governed data is the foundation AI needs. Clearsense says a national health system retired more than 800 legacy systems and generated over $100 million in recurring annual operating savings by archiving inactive records, and Harmony Healthcare IT’s 2023 CHIME CIO survey found 94% still operating on legacy applications.

  • 01A national health system retired more than 800 legacy systems and booked over $100 million in recurring annual operating savings by archiving inactive records, Clearsense says.
  • 02Harmony Healthcare IT's 2023 survey of health care CIOs found 94% still run legacy applications, and the average hospital carries 10 EHRs.
  • 03Across industries, 52% of chief data officers rate their generative AI data readiness inadequate, per an AWS and Harvard Business Review survey reported by HealthTech Magazine.

Nov 6, 2026

Censis now reads da Vinci 2D codes to count arm uses

Censis now reads da Vinci 2D codes to count arm uses

Censis Technologies told CtUC 2026 attendees that CensiTrac has read the 2D matrix code on da Vinci arms since April, so robotic arms carry use counts without a second mark. The session built a business case for CensiTrac Advanced around marked assembly, clinic inventory ownership and par levels, with a 2021 BMJ Quality & Safety study putting missing instruments at 17.6% of assembly defects.

  • 01CensiTrac has counted da Vinci arm uses from the code that already comes on each arm since April, with no laser or etch added.
  • 02Hospitals told Censis they want clinic inventory tracking mainly to prove sterile processing did not lose the instruments.
  • 03Missing instruments were 17.6% of assembly tray defects at a 700-bed hospital in a 2021 BMJ Quality & Safety study, a problem the presenter tied to marked assembly.

Nov 5, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512